aspartic acid has been researched along with methylphenidate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Garber, HJ; Oldendorf, WH; Stoller, BE; Tishler, TA | 1 |
| SIEGLER, PE | 1 |
| Bondi, CD; Kozikowski, AP; Kulkarni, SS; Newman, AH; Pan, S; Surratt, CK; Ukairo, OT | 1 |
| Alm, B; Colla, M; Deuschle, M; Ende, G; Heuser, I; Kronenberg, G | 1 |
| Acosta, MT; Arbelaez, A; Arcos-Burgos, M; Bailey-Wilson, JE; Balog, J; Castellanos, FX; Elia, J; Freitag, CM; Hakonarson, H; Hemminger, U; Jacob, C; Jain, M; Lesch, KP; Londoño, AC; Lopera, F; Meyer, J; Muenke, M; Palacio, JD; Palacio, LG; Palmason, H; Pineda, D; Renner, T; Roessler, E; Romanos, J; Romanos, M; Seitz, C; Swanson, J; Vélez, JI; Walitza, S; Warnke, A | 1 |
| Furuse, T; Kaneda, H; Kobayashi, K; Kushida, T; Masuya, H; Miura, I; Wada, Y; Wakana, S; Yamada, I; Yuasa, S | 1 |
| Bittsansky, M; Dobrota, D; Husarova, V; Ondrejka, I | 1 |
| Herken, H; Kenar, AN; Kiroglu, Y; Unal, GA | 1 |
| Calleros, OA; Campuzano, MR; Guillem, AM; Hernández-Kelly, LC; López-Bayghen, B; López-Bayghen, E; Martínez-Lozada, Z; Ortega, A | 1 |
| Albuz, B; Erdal, ME; Güler, H; Herken, H; Inci Kenar, AN; Kıroğlu, Y; Ünal, GA | 1 |
| Herken, H; İnci Kenar, AN; Kıroğlu, Y; Tepeli, E; Ünal, GA | 1 |
| Herken, H; Inci Kenar, AN; Kiroglu, Y; Unal, GA | 1 |
| Alkam, T; Kim, HC; Mamiya, T; Nabeshima, T; Nitta, A; Tanaka, J; Toriumi, K | 1 |
| James, GA; Padala, KP; Padala, PR; Samant, RS | 1 |
1 review(s) available for aspartic acid and methylphenidate
| Article | Year |
|---|---|
CURRENT STATUS OF DRUG TREATMENT IN THE DEPRESSIVE STATE.
Topics: Amitriptyline; Amphetamine; Amphetamines; Antidepressive Agents; Aspartic Acid; Benactyzine; Classification; Deanol; Depression; Desipramine; Humans; Imipramine; Isocarboxazid; Methylphenidate; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Pharmacology; Phenelzine; Phenmetrazine; Piperidines; Sympathomimetics; Toxicology; Tranylcypromine | 1964 |
1 trial(s) available for aspartic acid and methylphenidate
| Article | Year |
|---|---|
Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD.
Topics: Adult; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Brain; Choline; Dopamine Uptake Inhibitors; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Treatment Outcome | 2008 |
12 other study(ies) available for aspartic acid and methylphenidate
| Article | Year |
|---|---|
Methylphenidate increases rat cerebral cortex levels of N-acetyl-aspartic acid and N-acetyl-aspartyl-glutamic acid.
Topics: Animals; Aspartic Acid; Cerebral Cortex; Chromatography, High Pressure Liquid; Dipeptides; Male; Methylphenidate; Rats; Rats, Sprague-Dawley | 1994 |
Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Topics: Amino Acid Substitution; Animals; Aspartic Acid; Benztropine; Binding, Competitive; CHO Cells; Cocaine; Cricetinae; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Immunohistochemistry; Kinetics; Ligands; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Microscopy, Confocal; Models, Molecular; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Transfection | 2005 |
A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.
Topics: Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Brain; Case-Control Studies; Choline; Chromosomes, Human, Pair 11; Genetic Linkage; Genetic Predisposition to Disease; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Methylphenidate; Polymorphism, Single Nucleotide; Protons; Receptors, G-Protein-Coupled; Receptors, Peptide | 2012 |
Behavioral and neuromorphological characterization of a novel Tuba1 mutant mouse.
Topics: Analysis of Variance; Animals; Animals, Newborn; Aspartic Acid; Attention; Behavior, Animal; Bromodeoxyuridine; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Stimulants; Chromosome Mapping; Dark Adaptation; Developmental Disabilities; Disease Models, Animal; DNA Mutational Analysis; Dose-Response Relationship, Drug; Embryo, Mammalian; Ethylnitrosourea; Exploratory Behavior; Female; Gene Expression Regulation; Glycine; Homing Behavior; Male; Methylphenidate; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Electron, Transmission; Mutagenesis; Mutagens; Neocortex; Neurons; Phenotype; Time Factors; Tubulin | 2012 |
Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aspartic Acid; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Prefrontal Cortex; Propylamines; Treatment Outcome | 2014 |
Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study.
Topics: Adolescent; Adult; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebellum; Choline; Corpus Striatum; Creatine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Middle Aged; Prefrontal Cortex; Young Adult | 2015 |
Methylphenidate Increases Glutamate Uptake in Bergmann Glial Cells.
Topics: Animals; Aspartic Acid; Cell Line; Cell Membrane; Chick Embryo; Dopamine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Transporter 1; Glutamic Acid; Methylphenidate; Neuroglia; RNA; Up-Regulation | 2015 |
Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Topics: Administration, Oral; Adolescent; Adult; Alleles; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Cerebellum; Choline; Corpus Striatum; Creatine; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Middle Aged; Minisatellite Repeats; Polymorphism, Single Nucleotide; Prefrontal Cortex; Young Adult | 2016 |
Relationship between the SNAP-25 gene and the effects of methylphenidate on the anterior cingulate cortex of patients with adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Topics: Adult; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Methylphenidate; Middle Aged; Polymorphism, Genetic; Synaptosomal-Associated Protein 25 | 2016 |
Effects of methylphenidate treatment on the cerebellum in adult attention-deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Topics: Adolescent; Adult; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebellum; Choline; Creatine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Middle Aged; Young Adult | 2017 |
Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate.
Topics: Acetyltransferases; Amphetamine-Related Disorders; Animals; Aspartic Acid; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Methylphenidate; Mice, Knockout; Motor Activity | 2018 |
Improvement of neuronal integrity with methylphenidate treatment for apathy in Alzheimer's disease.
Topics: Affective Symptoms; Aged; Alzheimer Disease; Apathy; Aspartic Acid; Brain; Brain Chemistry; Central Nervous System Stimulants; Humans; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Receptors, Dopamine; Treatment Outcome | 2020 |